The Group’s H1 gross revenue saw a 3% growth year-on-year for the half, with some extremely strong performances from a number of key client accounts including GSK and Coca Cola. Strong growth was also reported from our Central, East and West African (CEWA), and Sub-Saharan (SSA), markets with 20% and 17% year-on-year gross revenue growth being achieved respectively.